Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Henry K. Tsai"'
Autor:
Brady S. Laughlin, Ronik S. Bhangoo, Joshua R. Niska, Cameron S. Thorpe, Marlene E. Girardo, Justin D. Anderson, Heidi E. Kosiorek, Lisa A. McGee, William F. Hartsell, John H. Chang, Carl J. Rossi, Henry K. Tsai, Isabelle J. Choi, Carlos E. Vargas
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Purpose/ObjectivesTo assess adverse events (AEs) and disease-specific outcomes after proton therapy for isolated local-regional recurrence (LRR) of breast cancer after mastectomy without prior radiotherapy (RT).Materials/MethodsPatients were identifi
Externí odkaz:
https://doaj.org/article/4d082877effa44838ed86aa178a4acf2
Autor:
Ali M. Saeed, MD, PhD, Rahul Khairnar, PhD, Ankur M. Sharma, MD, Gary L. Larson, MD, Henry K. Tsai, MD, Chiachien J. Wang, MD, PhD, Lia M. Halasz, MD, Prakash Chinnaiyan, MD, Carlos E. Vargas, MD, Mark V. Mishra, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 978-983 (2020)
Purpose: As a means of limiting normal tissue toxicity, proton-beam therapy (PBT) is an emerging radiation modality for glioblastoma (GBM) reirradiation. However, data for recurrent GBM treated with PBT reirradiation is limited. Therefore, we analyze
Externí odkaz:
https://doaj.org/article/fced426687ed42adbccb8dd8e0e902fa
Autor:
Benjamin T. Cooper, MD, Anuj Goenka, MD, Kevin Sine, CMD, Jae Y. Lee, MD, PhD, Brian H. Chon, MD, Henry K. Tsai, MD, Eugen B. Hug, MD, Hiral P. Fontanilla, MD
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 1, Pp 34-40 (2020)
Purpose: Quality assurance and continuing quality improvement are integral parts of any radiation oncology practice. With increasingly conformal radiation treatments, it has become critical to focus on every slice of the target contour to ensure adeq
Externí odkaz:
https://doaj.org/article/288415ea723e4122b587a7d07276f3b3
Autor:
Nathan Y. Yu, MD, Mauricio E. Gamez, MD, William F. Hartsell, MD, Henry K. Tsai, MD, George E. Laramore, MD, PhD, Gary L. Larson, MD, Charles B. Simone, II, MD, Carl Rossi, MD, Sanford R. Katz, MD, Matthew R. Buras, MS, Michael A. Golafshar, MS, Carlos E. Vargas, MD, Samir H. Patel, MD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 689-698 (2019)
Purpose: To report the outcomes of sinonasal tumors treated with proton beam therapy (PBT) on the Proton Collaborative Group registry study. Methods and Materials: Sixty-nine patients with sinonasal tumors underwent curative intent PBT between 2010 a
Externí odkaz:
https://doaj.org/article/ee6b8c11f16f49d089c23ecd99226265
Autor:
Rahul Khairnar, G.L. Larson, Carlos Vargas, Ankur M. Sharma, Prakash Chinnaiyan, Ali Saeed, Henry K. Tsai, Mark V. Mishra, Lia M. Halasz, Chiachien J Wang
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 978-983 (2020)
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 978-983 (2020)
Purpose: As a means of limiting normal tissue toxicity, proton-beam therapy (PBT) is an emerging radiation modality for glioblastoma (GBM) reirradiation. However, data for recurrent GBM treated with PBT reirradiation is limited. Therefore, we analyze
Autor:
G.L. Larson, Charles B. Simone, William F. Hartsell, Matthew R. Buras, Mauricio E. Gamez, Carlos Vargas, Nathan Y. Yu, George E. Laramore, Henry K. Tsai, C.J. Rossi, Michael A. Golafshar, Samir H. Patel, Sanford R. Katz
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 689-698 (2019)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose: To report the outcomes of sinonasal tumors treated with proton beam therapy (PBT) on the Proton Collaborative Group registry study. Methods and Materials: Sixty-nine patients with sinonasal tumors underwent curative intent PBT between 2010 a
Autor:
Henry K. Tsai, William F. Hartsell, Catherine E. Mercado, G.L. Larson, Charles B. Simone, Randal H. Henderson, He J. Zhu, Carlos Vargas, Bradford S. Hoppe, Jing Zeng
Publikováno v:
Acta Oncologica. 58:1036-1040
Objective: Thymic malignancies (TM) are rare tumors with long-term survivorship, causing concerns for radiotherapy-related late side effects. Proton therapy (PT) reduces the radiation dose to organ...
Autor:
Lia M. Halasz, Carlos Vargas, Shaakir Hasan, Charles B. Simone, Mark V. Mishra, Arpit M. Chhabra, Robert H. Press, John Han Chih Chang, Chiachien J Wang, Vinai Gondi, Henry K. Tsai, J. Isabelle Choi
Purpose: The optimal salvage treatment for malignant glioma after prior radiotherapy (RT) is not well established. Proton therapy (PT) is an attractive treatment modality for reirradiation (ReRT) of recurrent disease; however, data are limited.Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a50704a5a81bfe6b76673a51d79fbfa
https://doi.org/10.21203/rs.3.rs-499865/v1
https://doi.org/10.21203/rs.3.rs-499865/v1
Autor:
Henry K. Tsai, Lisa A. McGee, C.J. Rossi, William F. Hartsell, G.L. Larson, C.S. Thorpe, Marlene Girardo, L.R. Rosen, Carlos Vargas, J. Anderson, Joshua R. Niska
Publikováno v:
The breast journalREFERENCES. 26(9)
We investigated adverse events (AEs) and clinical outcomes for proton beam therapy (PBT) after breast-conserving surgery (BCS) for breast cancer. From 2012 to 2016, 82 patients received PBT in the prospective multi-institutional Proton Collaborative
Autor:
C.S. Thorpe, Carlos Vargas, Heidi E. Kosiorek, Henry K. Tsai, G.L. Larson, C.J. Rossi, L.R. Rosen, William F. Hartsell, Marlene Girardo, Joshua R. Niska, Lisa A. McGee
Publikováno v:
The breast journalREFERENCES. 25(6)
To investigate adverse events (AEs, CTCAE v4.0) and clinical outcomes for proton beam therapy (PBT) reirradiation (reRT) for breast cancer. From 2011 to 2016, 50 patients received PBT reRT for breast cancer in the prospective Proton Collaborative Gro